AstraZeneca Pharma India today said its board has agreed to seek shareholders' approval for the voluntary delisting of equity shares on various bourses.
The company's board has approved to seek shareholders' approval through postal ballot for the voluntary delisting of equity shares as proposed by AstraZeneca Pharmaceuticals AB, Sweden, promoter of the company, AstraZeneca Pharma India said in a filing to the BSE.
Last month, the company had fixed the floor price of Rs 854.1 apiece for delisting its shares from stock exchanges.
AstraZeneca Pharmaceuticals AB, Sweden, holds 75 per cent stake in AstraZeneca Pharma India.
In March, AstraZeneca Pharma had received by email a letter from the promoter proposing to make a voluntary delisting offer to the public shareholders from stock exchanges.
On March 18 it had announced that its board approved delisting of the company's shares from bourses.
AstraZeneca Pharma scrip closed at Rs 1,101 on the BSE, down 2.35 per cent, from its previous close.
